Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Cattle Health Market Size, Trends, Analysis, and Outlook By Therapeutics (Vaccine, Parasiticide, Anti-infective, Medical Feed Additive, Others), By Diagnostics (Immunodiagnostic Test, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, Others), by Country, Segment, and Companies, 2024-2032
... global Cattle Health market size is poised to register 8.2% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cattle Health market across ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market Size, Trends, Analysis, and Outlook By Therapeutics (Marketed Drugs, Pipeline Drugs), By Diagnostics (Lumbar Puncture Test, Computed Tomography Scan, Magnetic Resonance Imaging, Electroencephalography, Positron Emission Tomography Scan, Others), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Alzheimer's Disease Diagnostics and Therapeutics market size is poised to register 5.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Global Hyperkalemia Drugs Market - 2024-2031
... period 2024-2031. Hyperkalemia is a condition with too much potassium in the blood above the average level. Hyperkalemia happens if the kidneys do not work well which leads to life-threatening heart rhythm changes or cardiac ... Read More
-
AI In Genomics Market Size, Trends, Analysis, and Outlook By Offering (Software, Services), By Technology (Machine Learning, Others), By Function (Genome Sequencing, Gene Editing, Clinical Workflows, Predictive Genetic Testing & Preventive Medicine), By Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Agriculture & animal Research, Others), By End-User (Pharmaceutical & Biotech Companies, Healthcare Providers, Research Centers, Academic Institutes, Government Organizations, Others), by Country, Segment, and Companies, 2024-2032
... Drug Discovery & Development, Precision Medicine, Agriculture & animal Research, Others), By End-User (Pharmaceutical & Biotech Companies, Healthcare Providers, Research Centers, Academic Institutes, Government Organizations, Others), by Country, Segment, and Companies, 2024-2032 The global AI ... Read More
-
Osteoarthritis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 4.74% during the forecast period (2024-2029). The COVID-19 pandemic had a short-term impact on the market growth as it led to the cancelation or postponement of the ... Read More
-
Small Molecule Drug Discovery Market Size, Trends, Analysis, and Outlook By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others), By Process (Target ID/Validation, Hit Generation and Selection, Lead Identification, Lead Optimization), by Country, Segment, and Companies, 2024-2032
... by Country, Segment, and Companies, 2024-2032 The global Small Molecule Drug Discovery market size is poised to register 8.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Biomarker Technologies Market Size, Trends, Analysis, and Outlook By Product (Instruments, Assay and Reagents, Consumables), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, Others), By Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032
... Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032 The global Biomarker Technologies market size is poised to register 14.1% growth from 2024 to 2032, presenting significant growth prospects ... Read More
-
New Drug Approvals and Their Contract Manufacture - 2024 Edition
... performance. New Drug Approvals and Their Contract Manufacture (formerly called CMO Scorecard) is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition ... Read More
-
Bioinformatics Services Market Size, Trends, Analysis, and Outlook By Application (Genomics, Chemoinformatics, Proteomics, Transcriptomics, Metabolomics, Others), By Type (Sequencing Services, Data Analysis, Drug Discovery Services, Differential Gene Expression Analysis, Database and Management Services, Others), By Industry (Medical, Animal, Plant, Environmental, Forensic), By End-User (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, CROs, Others), by Country, Segment, and Companies, 2024-2032
... Industry (Medical, Animal, Plant, Environmental, Forensic), By End-User (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, CROs, Others), by Country, Segment, and Companies, 2024-2032 The global Bioinformatics Services market size is ... Read More
-
Acne Vulgaris (AV) - Competitive Landscape
... in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for AV. Topical retinoids and topical antibiotics are usually the first-line therapy for mild-to-moderate acne. The R&D activity is moderate within the AV space, ... Read More
-
Me Too Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Beta Blockers, Antidepressants, Statins, Proton Pump Inhibitors, Benzodiazepines, Others), By Therapeutic Area (Oncology, Diabetes, Hepatitis C, Cardiovascular, Others), By Region and Competition, 2019-2029F
... By Region and Competition, 2019-2029F Global Me Too Drugs Market was valued at USD 364.81 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.87% through ... Read More
-
Anti-obesity Drugs Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increased Prevalence of Obesity Over the past few decades, obesity ... Read More
-
Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034
... industry and its inherent dynamics. It provides valuable insights for firms interested in diversifying across various sectors or expanding their current activities into new geographical areas. Rise in IBD Incidence to Boost the Demand of ... Read More
-
Gaucher Disease Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2024-2032
... The global Gaucher disease market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. ... Read More
-
Metabolomics Market Report by Product (Metabolomics Instruments, Metabolomics Bioinformatics Tools and Services), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others), Application (Biomarker and Drug Discovery, Toxicology, Nutrigenomics, Personalized Medicine, and Others), and Region 2024-2032
... and Region 2024-2032 The global metabolomics market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.1% ... Read More
-
Human Growth Hormone Market Report by Application (Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS), Small for Gestational Age, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous, Oral), and Region 2024-2032
... Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous, Oral), and Region 2024-2032 The global human growth hormone market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.9 ... Read More
-
Duchenne Muscular Dystrophy Drugs Market by Product Type (Corticosteroids, Pain Management Drugs), Therapeutic Approach (Mutation Suppression, Exon Skipping, Steroid Therapy), End User (Hospitals, Clinics, Home Care Settings), and Region 2024-2032
... drugs market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 9.96% during 2024-2032. The rising prevalence ... Read More
-
Resistant Hypertension (RH) - Competitive Landscape
... in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for RH. The marketed drugs space for RH is dominated by off-label antihypertensive therapies. The R&D activity is limited within the RH space, with ... Read More
-
Psychedelics Therapeutics Development and Trends, 2024
... including regulatory, clinical, and market dynamics. The report identifies the broader changes within the evolving psychedelic industry, facilitating informed decision-making for relevant sectors. Scope This 36-page report gives important, expert insight you won’t find in ... Read More
-
Global AI in Drug Discovery Market 2024
... and predictive analytics, pharmaceutical companies can expedite the discovery of innovative therapeutics, improve patient outcomes, and address unmet medical needs more effectively. The global AI in drug discovery market was valued at USD 991.2 million ... Read More
-
Primary Progressive Multiple Sclerosis- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
5-Alpha Reductase Inhibitor - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
-
Transverse Myelitis - Pipeline Insight, 2024
... picture of the Transverse Myelitis pipeline landscape is provided, which includes the disease overview and Transverse Myelitis treatment guidelines. The assessment part of the report embraces in-depth Transverse Myelitis commercial assessment and clinical assessment of ... Read More
-
5-HT2B Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
20s Proteasome Inhibitor - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
Research Assistance
